Global Ferroptosis Targeting Therapy Clinical Trials Market 2024 - Clinical Trials Insight on 10+ Key Therapies in Trials
29 mai 2024 07h37 HE | Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Global Ferroptosis Targeting Therapy Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....
IMAC Holdings Announces Leadership Succession
24 mai 2024 09h00 HE | IMAC Holdings, Inc.
Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the...
Single Domain Antibody Platforms MarketResearch 2024-2031: Strategic Collaborations Driving Expansion, Focus on Pioneering Cancer Treatments, US Leads Innovations
24 mai 2024 04h28 HE | Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Single Domain Antibody Platforms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Director of the Ivy Brain Tumor Center and director of neurosurgical oncology at Barrow Neurological Institute
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
23 mai 2024 17h09 HE | Ivy Brain Tumor Center
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) -- Results will be presented at American Society of Clinical Oncology (ASCO) Annual MeetingMedian overall survival was 20.3 months, nearly doubling the...
Global Flow Cytometry Market Report 2024-2029, Featuring Agilent Technologies, BD, Bio-Rad Laboratories, Cytek Biosciences, Danaher, Miltenyi Biotec, Sony Biotechnology and Standard Biotools
15 mai 2024 09h48 HE | Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Flow Cytometry: Products, Technologies and Global Markets 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global market...
Science 37 Logo.jpg
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
13 mai 2024 08h00 HE | Science 37, Inc.
Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation.
Science 37 Logo.jpg
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
09 mai 2024 10h00 HE | Science 37, Inc.
Science 37 announces its selection as the winner of the “Clinical Efficiency Innovation Award” in the 8th annual MedTech Breakthrough Awards program.
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
07 mai 2024 08h30 HE | IMAC Holdings, Inc.
FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ:...
Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Research Agent
06 mai 2024 08h00 HE | Medeloop
MENLO PARK, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Medeloop, a trailblazer AI platform for clinical research is proud to announce the addition of Amir Dan Rubin to its board of directors. Rubin's...
Science 37 Logo.jpg
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
02 mai 2024 08h00 HE | Science 37, Inc.
Science 37's Metasite™ and Patient Recruitment Solutions together dramatically boost patient enrollment in a Phase 3 asthma clinical trial.